Issue 1/2009
Content (24 Articles)
An association between invasive breast cancer and familial idiopathic hyperparathyroidism: a case series and review of the literature
Sumanta Kumar Pal, Kathleen Blazer, Jeffrey Weitzel, George Somlo
Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival
Andrea C. Bafford, Harold J. Burstein, Christina R. Barkley, Barbara L. Smith, Stuart Lipsitz, James D. Iglehart, Eric P. Winer, Mehra Golshan
Role of melatonin in the epigenetic regulation of breast cancer
Ahmet Korkmaz, Emilio J. Sanchez-Barcelo, Dun-Xian Tan, Russel J. Reiter
PE38KDEL-loaded anti-HER2 nanoparticles inhibit breast tumor progression with reduced toxicity and immunogenicity
Jie Gao, Geng Kou, Hao Wang, Huaiwen Chen, Bohua Li, Ying Lu, Dapeng Zhang, Shuhui Wang, Sheng Hou, Weizhu Qian, Jianxin Dai, Jian Zhao, Yanqiang Zhong, Yajun Guo
Disruption of estrogen receptor α-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy
Wensheng Liu, Margot M. Ip, Matthew B. Podgorsak, Gokul M. Das
Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives
A-Yong Cao, Juan Huang, Zhen Hu, Wen-Feng Li, Zhong-Liang Ma, Li-Li Tang, Bin Zhang, Feng-Xi Su, Jie Zhou, Gen-Hong Di, Kun-Wei Shen, Jiong Wu, Jin-Song Lu, Jian-Min Luo, Wen-Tao Yuan, Zhen-Zhou Shen, Wei Huang, Zhi-Ming Shao
Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells
S. Hiscox, N. J. Jordan, C. Smith, M. James, L. Morgan, K. M. Taylor, T. P. Green, R. I. Nicholson
A common Greenlandic Inuit BRCA1 RING domain founder mutation
Thomas v. O. Hansen, Bent Ejlertsen, Anders Albrechtsen, Eva Bergsten, Peter Bjerregaard, Torben Hansen, Torben Myrhøj, Peter B. Nielsen, Vera Timmermans-Wielenga, Mette K. Andersen, Lars Jønson, Finn C. Nielsen
Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome
Malini Harigopal, Jonas Heymann, Sriparna Ghosh, Valsamo Anagnostou, Robert L. Camp, David L. Rimm
A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer
G. Fountzilas, U. Dafni, M. A. Dimopoulos, A. Koutras, D. Skarlos, P. Papakostas, H. Gogas, D. Bafaloukos, A. Kalogera-Fountzila, E. Samantas, E. Briasoulis, D. Pectasides, N. Maniadakis, F. Matsiakou, G. Aravantinos, C. Papadimitriou, M. Karina, C. Christodoulou, P. Kosmidis, H. P. Kalofonos
Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902
Johanna G. H. van Nes, Hein Putter, Jean-Pierre Julien, Michelle Tubiana-Hulin, Marc van de Vijver, Jan Bogaerts, Monika de Vos, Cornelis J. H. van de Velde
Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer
Maura N. Dickler, Melody A. Cobleigh, Kathy D. Miller, Pamela M. Klein, Eric P. Winer
The impact of sharing results of a randomized breast cancer clinical trial with study participants
Ann H. Partridge, A. C. Wolff, P. K. Marcom, P. A. Kaufman, L. Zhang, R. Gelman, C. Moore, D. Lake, G. F. Fleming, H. S. Rugo, J. Atkins, E. Sampson, D. Collyar, E. P. Winer
Epirubicin plus low-dose trastuzumab in HER2 positive metastatic breast cancer
Alessandra Gennari, Michele De Tursi, Consiglia Carella, Enrico Ricevuto, Cinzia Orlandini, Antonio Frassoldati, Pierfranco Conte, Paolo Bruzzi, Stefano Iacobelli
Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures
Mostafa Saadat, Maryam Ansari-Lari
The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case–control and family analysis
Sharon E. Johnatty, Jonathan Beesley, Xiaoqing Chen, John L. Hopper, Melissa C. Southey, Graham G. Giles, David E. Goldgar, Georgia Chenevix-Trench, Amanda B. Spurdle
Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics
Lina Mu, Dionyssios Katsaros, Andrew Wiley, Lingeng Lu, Irene A. Rigault de la Longrais, Stephanie Smith, Sapna Khubchandani, Olga Sochirca, Riccardo Arisio, Herbert Yu
Ethnic differences in the use of regular mammography: the multiethnic cohort
Quannetta T. Edwards, Arthur X. Li, Malcolm C. Pike, Laurence N. Kolonel, Giske Ursin, Brian E. Henderson, Roberta McKean-Cowdin
Circulating steroid hormone concentrations in postmenopausal women in relation to body size and composition
Laura Baglietto, Dallas R. English, John L. Hopper, Robert J. MacInnis, Howard A. Morris, Wayne D. Tilley, Kavitha Krishnan, Graham G. Giles
Screening caused rising incidence rates of ductal carcinoma in situ of the breast
L. N. van Steenbergen, A. C. Voogd, J. A. Roukema, W. J. Louwman, L. E. M. Duijm, J. W. W. Coebergh, L. V. van de Poll-Franse
No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study
Timothy R. Rebbeck, Antonis C. Antoniou, Trinidad Caldes Llopis, Heli Nevanlinna, Kristiina Aittomäki, Jacques Simard, Amanda B. Spurdle, Fergus J. Couch, Lutecia H. Mateus Pereira, Mark H. Greene, Irene L. Andrulis, Boris Pasche, Virginia Kaklamani, Ute Hamann, Csilla Szabo, Susan Peock, Margaret Cook, Patricia A. Harrington, Alan Donaldson, Allison M. Male, Carol Anne Gardiner, Helen Gregory, Lucy E. Side, Anne C. Robinson, Louise Emmerson, Ian Ellis, Jean-Philippe Peyrat, Joëlle Fournier, Philippe Vennin, Claude Adenis, Danièle Muller, Jean-Pierre Fricker, Michel Longy, Olga M. Sinilnikova, Dominique Stoppa-Lyonnet, Rita K. Schmutzler, Beatrix Versmold, Christoph Engel, Alfons Meindl, Karin Kast, Dieter Schaefer, Ursula G. Froster, Georgia Chenevix-Trench, Douglas F. Easton
Overweight, obesity and breast cancer prognosis: optimal body size indicator cut-points
Bilal Majed, Thierry Moreau, Bernard Asselain
Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer?
S. J. Beyer, R. E. Jimenez, C. L. Shapiro, J. Y. Cho, S. M. Jhiang
Prepubertal physical activity up-regulates estrogen receptor β, BRCA1 and p53 mRNA expression in the rat mammary gland
M. Wang, B. Yu, K. Westerlind, R. Strange, G. Khan, D. Patil, K. Boeneman, L. Hilakivi-Clarke